Pre-Open Stock Movers 12/12: (CCXI) (TLM) (GPRO) Higher; (EOX) (GDP) (MEIP) Lower (more...)

December 12, 2014 9:31 AM EST Send to a Friend
ChemoCentryx, Inc., (Nasdaq: CCXI) 88.3% HIGHER; announced positive top-line 52-week data from its Phase II clinical trial in diabetic nephropathy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login